Detalhe da pesquisa
1.
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
Br J Cancer
; 130(3): 476-482, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135713
2.
Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer.
Ann Surg
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506042
3.
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Lancet
; 402(10409): 1272-1281, 2023 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708904
4.
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers.
Oncologist
; 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330461
5.
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Lancet Oncol
; 24(8): 925-935, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541273
6.
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.
Lancet Oncol
; 24(7): 772-782, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276871
7.
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.
Lancet Oncol
; 24(12): 1387-1398, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039992
8.
Phase 1b study of pan-AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN-mutated advanced solid tumors.
Cancer
; 129(12): 1919-1929, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36970876
9.
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors.
Cancer
; 129(10): 1537-1546, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882377
10.
Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma.
Ann Surg
; 277(3): 484-490, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36649067
11.
Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial.
Ann Surg
; 278(1): 22-30, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026453
12.
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.
Oncologist
; 28(12): 1100-e1292, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311055
13.
Phase 1 study of the safety, pharmacokinetics, and preliminary efficacy of CA102N as monotherapy and in combination with trifluridine-tipiracil in patients with locally advanced or metastatic solid tumors.
Invest New Drugs
; 41(1): 25-34, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331676
14.
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer.
Gynecol Oncol
; 168: 76-82, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423446
15.
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study.
Lancet Oncol
; 23(12): 1558-1570, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400106
16.
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.
Invest New Drugs
; 40(5): 990-1000, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767205
17.
PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer.
BMC Cancer
; 22(1): 14, 2022 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980020
18.
Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer.
Ann Surg
; 273(4): 806-813, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31274655
19.
Pancreas Cancer-Associated Pain Management.
Oncologist
; 26(6): e971-e982, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33885205
20.
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.
Oncologist
; 26(7): 588-596, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33783054